Registered outcomes14

Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.

1 to 14 of 14

List	Outcome	Time frame
Primary	Postprandial increase in intact proinsulin levels in patient treated with Vildagliptin and Metformin compared to intact proinsulin levels in patients treated with Glimepiride and Metformin (Area under the curve 0-300 min)	One year
Secondary	Fasting intact proinsulin levels	One year
Secondary	Max postprandial intact proinsulin levels	One year
Secondary	Retinal endothelial response to flicker light stimulation	One year
Secondary	Mean 24h systolic and diastolic blood pressure	One year
Secondary	Erythrocyte deformability	One year
Secondary	E-selectin	One year
Secondary	Change in body weight	One year
Secondary	hsCRP	One year
Secondary	HbA1c	One year
Secondary	Fasting blood glucose	One year
Secondary	Number of hypoglycemic events	One year
Secondary	Adverse events	One year
Secondary	Drug related adverse events	One year

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT01565096/registered